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In a study by Hofstra and colleagues [1] in a recent issue 
of Critical Care, nebulization of drotrecogin-alfa (activated), 
antithrombin, heparin, or danaparoid attenuated pulmo-
nary coagulopathy during Streptococcus pneumoniae 
pneumonia in rats; only antithrombin additionally 
exerted lung-protective eﬀ   ects and reduced bacterial 
outgrowth. Adding antithrombin to culture medium had 
no eﬀ  ect on the outgrowth of S. pneumoniae in vitro; 
thus, less neutralizing of endogenous antimicrobicidals 
by reduced bronchoalveolar ﬂ  uid levels of inﬂ  ammatory 
proteins could have permitted better endogenous 
microbicidal eﬀ  ects in the antithrombin group [1].
Direct microbicidal eﬀ  ects of antithrombin would not 
have been surprising since antimicrobial peptides are 
known to bind to glycosaminoglycans similar to anti-
thrombin [2]. Structural motifs associated with heparin 
aﬃ   nity confer antimicrobial properties to a given peptide 
[3]. Th  us, heparin-binding peptides (for example, from 
laminin isoforms, von Willebrand factor, vitronectin, 
protein C inhibitor, complement factor C3, and ﬁ  bro-
nectin) exerted antimicrobial activities against bacteria 
[3]. Similar results had been obtained using consensus 
sequences for heparin binding (Cardin and Weintraub 
motifs) determined as -X-B-B-X-B-X- and -X-B-B-B-X-X-
B-X- (B: probability of a basic residue; X: hydropathic 
residue) [4]. Antithrombin contains such a consensus 
sequence (130L-Y-R-K-A-N-K-S) [4,5].
When investigating the ligation of glycosaminoglycans 
with endogenous antimicrobials [2], we also studied the 
direct eﬀ  ects of antithrombin on bacterial growth, and 
growth inhibition was found (C.J. Wiedermann, A. 
Djanani, unpublished data). It is therefore unclear why 
Hofstra and colleagues [1] failed to observe a direct 
inhibition of bacterial growth by antithrombin. Reasons 
may include (a) dose and duration of antithrombin 
exposure of bacteria and (b) microbial species. Given the 
authors’ interesting observation, however, to further 
explore the direct antimicrobial potential of nebulized 
anti  thrombin in the lung would be worthwhile.
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